{"data":{"type":"company_profile_ai","id":91083,"entity_id":"wefunder:company:91083","attributes":{"canonical_url":"https://wefunder.com/viit.health","retrieval_urls":{"canonical":"https://wefunder.com/viit.health","json":"https://wefunder.com/viit.health.json","markdown":"https://wefunder.com/viit.health.md","ai_json":"https://wefunder.com/viit.health.ai.json","ai_text":"https://wefunder.com/viit.health.ai.txt","changelog_json":"https://wefunder.com/viit.health.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-05T23:53:30Z","generated_at":"2026-06-06T03:14:17Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":91083,"entity_id":"wefunder:company:91083","slug":"viit.health","name":"Viit Health","tagline":"Extending Lives through Light and Intelligence ","elevator_pitch":"Viit Health develops computer vision technology for non-invasive health monitoring. We create integral consumer healthcare solutions comprised of portable electronic devices, Artificial Intelligence models, and user friendly software applications, which are used together to accurately identify different biomarkers –blood glucose levels, SpO2, heart rate, blood pressure, and more– and derive meaningful personalized prevention and wellness insights from the data. Our hardware uses advanced optical techniques such as Near Infrared Spectroscopy (NIR), Photoplethysmography (PPG), and Light Rotation (LR) to identify the spectral footprint of particular biochemical compounds in human tissue and volumetric variations of the blood. Such data is then analyzed by intelligent image processing algorithms that comprise Classical \u0026amp; Deep Learning models, which can determine the correct level of each biomarker. Finally, the results are displayed through user-friendly prevention applications that can also share personalized recommendations to increase overall wellness (for clinical and individual use).","location":"Mesa, United States","website":"https://www.viit.health","total_amount_raised":883381,"total_investors":910,"is_funded":false,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 883381","citation":"https://wefunder.com/viit.health#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-05T23:53:30Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-06T23:53:30Z"},{"claim_id":"claim-total-investors","text":"Total investors: 910","citation":"https://wefunder.com/viit.health#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-05T23:53:30Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-06T23:53:30Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 883381","citation":"https://wefunder.com/viit.health#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-05T23:53:30Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-06T23:53:30Z"},{"claim_id":"claim-total-investors","text":"Total investors: 910","citation":"https://wefunder.com/viit.health#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-05T23:53:30Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-06T23:53:30Z"}],"company_claims":{"tagline":"Extending Lives through Light and Intelligence ","elevator_pitch":"Viit Health develops computer vision technology for non-invasive health monitoring. We create integral consumer healthcare solutions comprised of portable electronic devices, Artificial Intelligence models, and user friendly software applications, which are used together to accurately identify different biomarkers –blood glucose levels, SpO2, heart rate, blood pressure, and more– and derive meaningful personalized prevention and wellness insights from the data. Our hardware uses advanced optical techniques such as Near Infrared Spectroscopy (NIR), Photoplethysmography (PPG), and Light Rotation (LR) to identify the spectral footprint of particular biochemical compounds in human tissue and volumetric variations of the blood. Such data is then analyzed by intelligent image processing algorithms that comprise Classical \u0026amp; Deep Learning models, which can determine the correct level of each biomarker. Finally, the results are displayed through user-friendly prevention applications that can also share personalized recommendations to increase overall wellness (for clinical and individual use).","story":"Viit Health is entering commercialization — and as we begin scaling, we’re giving the WeFunder community access to a private Pre-Series A opportunity with preferred terms and exciting special perks!Our mission is bold: reshape the future of healthcare by making prevention simple, personalized, and accessible — helping extend 1 million lives by 10 healthy years over the next decade.Viit has built a non-invasive health monitoring platform that combines a pocket-sized optical device, AI-powered analytics, and personalized insights. Using light instead of needles or consumables, Viit measures blood glucose, blood pressure, oxygen saturation, heart rate, and other key biomarkers in under 30 seconds.With fast, painless monitoring and real-time personalized insights, Viit is designed to help detect early signs of health risk before disease progresses — empowering people, clinicians, and organizations to act sooner and help people stay healthier for longer.Today’s healthcare system is not truly built around health — it is built around disease.Non-communicable diseases (NCDs) like hypertension, heart disease, diabetes, and other metabolic disorders account for over 70% of deaths globally — claiming more than 40 million lives each year. Often symptomless in early stages, conditions like high blood pressure — affecting more than 1.2 billion people worldwide — or glucose-related dysfunction — estimated to impact half the world’s population — progress silently until disease becomes unavoidable.These threats, driven by sedentary lifestyles, poor nutrition, chronic stress, and inequitable access to healthcare, can lead to heart attacks, strokes, kidney failure, and neurodegenerative conditions. The crisis isn’t just medical — it’s a failure of early detection and accessible prevention.Monitoring vital health markers like blood glucose, blood pressure, and oxygen saturation remains a slow, fragmented, and costly process—especially for those at risk of chronic disease. Individuals often need multiple separate devices, each requiring setup, calibration, and manual interpretation.Blood glucose tracking, for example, still relies on painful finger pricks or expensive continuous monitors that involve frequent sensor insertions—costing users up to $3,600 annually. For many, especially those already managing complications like neuropathy, these tools are not just uncomfortable—they are unsustainable. At the clinic level, conducting a full assessment of basic vitals can take up to 17 minutes and cost nearly $15 per patient. These inefficiencies not only drive up costs but discourage consistent monitoring, delay diagnosis, and ultimately make prevention inaccessible for millions.Viit Health uses light and AI to measure key health biomarkers in a fast, painless, and non-invasive way. In 30 seconds, our device can measure blood glucose, blood pressure, oxygen saturation, heart rate, and more — without finger pricks, consumables, or multiple devices.Traditional clinical measurements can take up to 17 minutes and cost more than $15 per patient. Viit can complete a measurement in seconds for as little as $0.20, reducing time by up to 97% and cost by up to 98%.Our proprietary, patent-pending technology combines multiple optical and sensing methods into a compact device, connected to AI-powered software for signal analysis, longitudinal tracking, and personalized insights. This integrated approach allows us to capture stronger physiological signals and deliver more accurate, actionable health insights than single-sensor or algorithm-first solutions.Instead of overwhelming users with too much data, Viit focuses on the insights that matter most. By combining high-quality signals, efficient hardware, and AI, we aim to make real-time health monitoring more accessible for individuals, clinics, companies, and public health programs.Over seven years of R\u0026amp;D and multiple generations of device innovation, Viit Health has refined its proprietary technology through extensive calibration, signal optimization, and clinical validation. Since 2018, we’ve collaborated with leading healthcare institutions in the U.S. and Mexico, deploying 5 clinical studies and validating our technology in over 3,900 individuals to date.With current results showing 3.4 BPM Mean Absolute Error (MAE) for heart rate, 0.9% MAE for SpO₂, 4.1 - 7.2 mmHg MAE for blood pressure, and 6.4 - 15.7 mg/dL MAE for blood glucose levels, we have closed the gap between non-invasive wellness monitoring and clinical-grade performance. Over the next 18 months, we will complete FDA regulatory approval as a Clinical Decision Support System (CDSS) aimed toward cardiometabolic risk observation.* Preliminary results in controlled clinical settings / 1) Mean Absolute Error / 2) Calculated against gold-standard references / 3) Latest preliminary results obtained through cross-sectional and OGTT clinical studies for a wide glycemic range (49 - 489 mg/dL).Our active clinical studies are in two of the largest hospitals in Mexico: Hospital General de México and Hospital Juárez de México.Prevention is the only sustainable way to reduce the burden of chronic disease. Yet today, large-scale screening remains slow, expensive, and fragmented, making it difficult for organizations to identify risk early and act before health problems become more serious.Viit Health is built for population-level clinical monitoring. Our Hardware \u0026amp; Software-as-a-Service model, starting at $550 per month, combines non-invasive measurement devices, monitoring software, healthy habits coaching, and clinical oversight into one scalable service. This enables employers, clinics, hospitals, public health programs, and institutional partners to monitor key cardiometabolic biomarkers across large groups over time.Rather than selling hardware alone, Viit delivers a complete monitoring platform that helps organizations track health trends, identify emerging risks, and support earlier preventive action. In parallel, we will also license our technology to strategic distribution partners, allowing Viit to scale through established commercial channels while expanding access to preventive health monitoring.By reducing the time, cost, and complexity of traditional screening, Viit makes prevention practical at scale.Viit Health is directly addressing a $780B+ global market opportunity driven by the shift toward personalized, preventive healthcare. With an initial focus on North and Latin America, we see a $338B total addressable market, a $119B serviceable available market, and a $2.97B near-term obtainable market based on targeted deployment for which there are already active conversations.More than 2 billion people are living with or at high risk of metabolic and cardiovascular conditions, often without consistent access to early detection or preventive monitoring. As existing tools remain inefficient, expensive, and hard to scale, Viit Health offers a timely alternative: accessible, non-invasive, real-time monitoring designed for everyday use and population-level impact.CROP marks Viit Health’s commercial activation.This November, we will launch a paid, multi-center Cardiometabolic Risk Observation Program (CROP) under the supervision of the Hospital General de México.Together with InBody and Daily Human, we are preparing to deploy 180 Viit Gen-4 units across corporate wellness initiatives, monitor 20,000+ people over 18 months, and generate approximately $3M in revenue.The program combines Viit’s fast, non-invasive biomarker monitoring with InBody’s body composition analysis and Daily Human’s AI-powered healthy habits coaching — creating a scalable model for prevention, early risk observation, and long-term behavior change.CROP is designed to show how Viit can bring prevention into real-world settings — helping organizations monitor cardiometabolic risk earlier, more frequently, and at scale.Leading health experts, scientists, and investors recognize the urgent need for better tools to detect and manage chronic disease risk. That’s why Viit Health has gained support from a growing network of partners — including top research institutions in Mexico and the U.S., global health investors, engineering firms, and entrepreneurship organizations. Together, we’re building one of the most promising breakthroughs in consumer health: a scalable, science-backed platform for prevention that’s ready for the real world.Viit Health is led by a rare combination of scientific expertise, financial acumen, and mission-driven entrepreneurship. Our team brings decades of experience across biotech, engineering, clinical research, and venture building — paired with a deep commitment to advancing public health through innovation. We’ve built and scaled startups, secured global partnerships, led cutting-edge research, and executed in both corporate and clinical environments. With a clear vision and a strong operational foundation, we’re committed to delivering measurable value for both our users and investors — while creating lasting impact in the fight against chronic disease.Following our initial CROP deployment and first commercial revenue, Viit Health plans to raise a $3M Series A to accelerate the next phase of growth.This round is expected to support regulatory execution, manufacturing scale-up, and preparation for broader commercial expansion. In January 2027, we will begin submissions with both the FDA and COFEPRIS as a Clinical Decision Support System (CDSS) for cardiometabolic risk observation, with approvals targeted by the end of 2027.As we move through the regulatory process, we also plan to expand CROP by 220 additional units by July 2027, strengthening our real-world dataset and commercial traction.By early 2028, Viit Health aims to begin broader expansion across the U.S. and Mexico, targeting pre-identified institutional channels for population-level monitoring. After 2028, we intend to expand across Latin America and add new biomarker capabilities such as oxidative stress, cholesterol, triglycerides, HbA1c, and other cardiometabolic markers.The world faces a growing health and economic crisis: non-communicable diseases account for the vast majority of deaths, despite being largely preventable. What’s missing isn’t treatment — it’s access to early detection and practical prevention. Viit Health’s mission is to change that. After years of research, validation, and strategic partnerships, we’re ready to scale a breakthrough solution that delivers real-time, non-invasive health monitoring to individuals, healthcare providers, and public systems alike — with a model built for meaningful impact and strong, sustainable profitability.This is a chance to be part of a global shift — toward smarter tools, healthier lives, and a more sustainable future.","quick_facts":["Non-invasive AI platform measures 4+ biomarkers 97% faster and 98% cheaper than traditional tools","Proprietary patent-pending technology measures Glucose, Blood Pressure, SpO2, Heart Rate, and more","Validated in 3,900+ patients through 5 Clinical Trials with clinical-grade accuracy for all markers","Potential to predict 27+ diseases and 19+ complications, such as diabetes, hypertension and more","Paid pilot in deployment (Nov 2026): 180 units, 20K+ people, 18 months, $3M in projected revenue","$2.3M raised from leading private investors. $3M in R\u0026amp;D grants awarded to background dev company","Backed by leading US family office, two VCs, hospitals, public institutions \u0026amp; distribution partners","Startup World Cup finalist, Draper Founder \u0026amp; Softeq alumni, Hello Tomorrow DeepTech Pioneer"]},"computed_metrics":{"total_amount_raised":883381,"total_investors":910,"team_size":10,"featured_investor_count":4,"faq_count":5,"recent_post_count":10},"quick_facts":[{"claim_id":"claim-fact-1","value":"Non-invasive AI platform measures 4+ biomarkers 97% faster and 98% cheaper than traditional tools","citation":"https://wefunder.com/viit.health#claim-fact-1","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-2","value":"Proprietary patent-pending technology measures Glucose, Blood Pressure, SpO2, Heart Rate, and more","citation":"https://wefunder.com/viit.health#claim-fact-2","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-3","value":"Validated in 3,900+ patients through 5 Clinical Trials with clinical-grade accuracy for all markers","citation":"https://wefunder.com/viit.health#claim-fact-3","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-4","value":"Potential to predict 27+ diseases and 19+ complications, such as diabetes, hypertension and more","citation":"https://wefunder.com/viit.health#claim-fact-4","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-5","value":"Paid pilot in deployment (Nov 2026): 180 units, 20K+ people, 18 months, $3M in projected revenue","citation":"https://wefunder.com/viit.health#claim-fact-5","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-6","value":"$2.3M raised from leading private investors. $3M in R\u0026amp;D grants awarded to background dev company","citation":"https://wefunder.com/viit.health#claim-fact-6","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-7","value":"Backed by leading US family office, two VCs, hospitals, public institutions \u0026amp; distribution partners","citation":"https://wefunder.com/viit.health#claim-fact-7","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"},{"claim_id":"claim-fact-8","value":"Startup World Cup finalist, Draper Founder \u0026amp; Softeq alumni, Hello Tomorrow DeepTech Pioneer","citation":"https://wefunder.com/viit.health#claim-fact-8","observed_at":"2026-06-05T23:53:30Z","expires_at":"2026-06-12T23:53:30Z"}],"latest_fundraise":{"id":138683,"entity_id":"wefunder:fundraise:138683","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":1820234,"entity_id":"wefunder:company_role:1820234","name":"Luis Fernando Gomez","title":"CEO","role":"founder","profile_url":"https://wefunder.com/luisfernando2"},{"id":5694299,"entity_id":"wefunder:company_role:5694299","name":"Mayra Mora","title":"CTO","role":"employee","profile_url":"https://wefunder.com/mayra.mora"},{"id":1970925,"entity_id":"wefunder:company_role:1970925","name":"Antonio Garcia","title":"CSO","role":"employee","profile_url":"https://wefunder.com/antoniogarcia4"},{"id":5694300,"entity_id":"wefunder:company_role:5694300","name":"Victoria M. Merino","title":"CRO","role":"employee","profile_url":"https://wefunder.com/victoria.merino"},{"id":5694301,"entity_id":"wefunder:company_role:5694301","name":"Felix Agakov","title":"Artificial Intelligence","role":"employee"},{"id":3682321,"entity_id":"wefunder:company_role:3682321","name":"Adriana Monroy Guzmán","title":"Clinical Research","role":"employee","profile_url":"https://wefunder.com/adriana.monroy.guzmn"},{"id":1820713,"entity_id":"wefunder:company_role:1820713","name":"Luis Gomez Sanchez","title":"Government Relations","role":"founder","profile_url":"https://wefunder.com/luisgomez3"},{"id":5694302,"entity_id":"wefunder:company_role:5694302","name":"Lorena De La Maza","title":"Medical Relations","role":"founder"},{"id":1820516,"entity_id":"wefunder:company_role:1820516","name":"Gerardo Rioseco","title":"Finance","role":"employee"},{"id":3682320,"entity_id":"wefunder:company_role:3682320","name":"Sofia Alvarez","title":"Administration","role":"employee","profile_url":"https://wefunder.com/sofiaalvarez"}],"featured_investors":[{"id":11639,"entity_id":"wefunder:company_investor_profile:11639","name":"Softeq Venture Fund","bio":"The Softeq Venture Fund invests in early-stage technology companies and de-risks them with a unique model of Fund + Venture Studio + Engineering Services.","profile_url":"https://wefunder.com/softeq.venture.fund.1","endorsement_quote":"As General Partner at Softeq Venture Fund and MedScience Ventures, I am committed to supporting ventures that drive impact through innovation. Viit Health’s mission is fully aligned with this vision, offering scalable and effective solutions in personalized healthcare."},{"id":11640,"entity_id":"wefunder:company_investor_profile:11640","name":"Sabacica Capital","bio":"We are a women-led fund with a focus on increasing transgenerational wealth, backed by research. We do this by deploying capital to women and POC-led start-ups at the seed and series A stage.","profile_url":"https://wefunder.com/sabacica.capital.1","endorsement_quote":"Viit Health is tackling a key challenge in modern medicine—leveraging data to improve patient outcomes. Their approach aligns with my belief in supporting companies that combine strong technology with a clear path to market impact."},{"id":11641,"entity_id":"wefunder:company_investor_profile:11641","name":" Cienega Investments LLC ","profile_url":"https://wefunder.com/.cienega.investments.llc..2"},{"id":11669,"entity_id":"wefunder:company_investor_profile:11669","name":"Robert C Campbell","bio":"Investor, Entrepreneur and Executive. Founder \u0026amp; CEO of 365 Surgical. Strategic growth investor for several companies.","profile_url":"https://wefunder.com/robertccampbell","endorsement_quote":"I have known the team at VIIT Health for years. I am investing for three basic reasons: (1) the technology and product are a much-needed solution to help with the global diabetes epidemic as well as with broader lifestyle improvements for everyone; (2) the team is fantastic, from a technical perspective as well as from a business-acumen perspective; and (3) the scaling plan is viable: there is product-market fit with known customers and a path to scale. I could not be more excited about this opportunity and look forward to great things!"}],"relationships":[{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:1466685","target_url":"https://wefunder.com/luisfernando2"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:4764680","target_url":"https://wefunder.com/mayra.mora"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:1601519","target_url":"https://wefunder.com/antoniogarcia4"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:4787207","target_url":"https://wefunder.com/victoria.merino"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:company_role:5694301"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:3359423","target_url":"https://wefunder.com/adriana.monroy.guzmn"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:2358787","target_url":"https://wefunder.com/luisgomez3"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:company_role:5694302"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:company_role:1820516"},{"source_entity_id":"wefunder:company:91083","relation":"has_team_member","target_entity_id":"wefunder:user:3553244","target_url":"https://wefunder.com/sofiaalvarez"},{"source_entity_id":"wefunder:company:91083","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:15405","target_url":"https://wefunder.com/softeq.venture.fund.1"},{"source_entity_id":"wefunder:company:91083","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:15406","target_url":"https://wefunder.com/sabacica.capital.1"},{"source_entity_id":"wefunder:company:91083","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:8175","target_url":"https://wefunder.com/.cienega.investments.llc..2"},{"source_entity_id":"wefunder:company:91083","relation":"has_featured_investor","target_entity_id":"wefunder:user:3539313","target_url":"https://wefunder.com/robertccampbell"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:323853","target_url":"https://wefunder.com/feed/323853"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:226447","target_url":"https://wefunder.com/feed/226447"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:183225","target_url":"https://wefunder.com/feed/183225"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:183124","target_url":"https://wefunder.com/feed/183124"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:174903","target_url":"https://wefunder.com/feed/174903"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:174876","target_url":"https://wefunder.com/feed/174876"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:174858","target_url":"https://wefunder.com/feed/174858"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:174849","target_url":"https://wefunder.com/feed/174849"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:174833","target_url":"https://wefunder.com/feed/174833"},{"source_entity_id":"wefunder:company:91083","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:174783","target_url":"https://wefunder.com/feed/174783"},{"source_entity_id":"wefunder:company:91083","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:138683"}],"faq":[{"question":"Very intriguing opportunity that I'm strongly considering pending answers to the following questions: 1. Could you share the specificity and sensitivity of Gluco 1.0 compared to existing \"gold standard\" diagnostics (which I assume are the puncture-based methods you referenced)...","answer":"Dear Kenneth, Thanks for reaching out! It's a pleasure to meet you. 1 - As we move forward with validation protocols for Gluco 1.0, we've been improving our assertiveness and are currently working with a 10% error margin in lab tests, which we will work to improve further. Puncture glucometers currently have a ±20% error margin in glucose concentrations ≥75 mg/dl, since they must be compliant with ISO 15197:2003. 2 - To our knowledge, there are very few competitors developing similar devices ..."},{"question":"Truly appreciate your detailed response, Luis! I just invested and wish you and the team all the best with the years ahead. :-)","answer":"Thank you very much Kenneth! Welcome to the ViiT Health Team!"},{"question":"Hello, I like your plan to place this device in large institutions. How much do estimate your activation \u0026amp; monthly fees will be for the 3 price levels you have? Will the device have an option for battery operation? How robust is the unit? Does it require scheduled maintena...","answer":"Hi John, thanks for your interest, it's nice to meet you. 1. The activation price for each device at all levels will be $ 250 USD, and the monthly fees will vary according to the selected amount of glucose readings per month (subscription), which could average $30 USD for individual detection, $50 USD for clinical detection, and $100 USD for prevention (since it's thought to mainly be placed in mid-to-large companies for massive prevention campaigns). 2. Yes. Our current devices used for all ..."},{"question":"How do you intend to make money? Current monitoring systems make money from lancets and test strips. What is the breakdown of your revenue model?","answer":"Hi Robert. Nice to meet you and thanks for your interest. We look to make money by selling subscription plans for glucose readings which are aimed towards individuals, clinics/health institutions and prevention campaigns with mid-to-large sized companies. Each of the aforementioned channels constitute a revenue stream within our business model. All devices will cost $250 USD to purchase and activate (which could be covered by insurance companies). From then on, we will charge a monthly fee (o..."},{"question":"Hello, I am very curious and interested ... I got few questions... 1) What's your patent that competitors can't copy ... 2) How good is your test results with respect to the traditional model (anything you folks did ) 3) Any comparison with the constant monitoring (poke) thing...","answer":"Hello Murali. It's a pleasure. 1) Our technology is currently protected by Industrial Secret and we have not yet filed for a patent. We use Near Infrared Spectroscopy and Computer Vision technology, which enabled us to devise a new way to understand the information that results of shedding light of specific wavelength through live tissue, and isolate certain chemical components such as glucose, after training our AI algorithms to identify specific energy footprints. We may file for a patent l..."}],"recent_posts":[{"id":323853,"entity_id":"wefunder:feed_item:323853","title":"Viit Health Enters Commercial Deployment","preview":"Hello everyone!We are entering one of the most important stages in Viit Health’s journey.After years of development we are preparing our first large-scale deployment in Mexico and the United States.To support this next phase, Viit Health is opening a private round for accredited investors with preferred terms through WeFunder.We are raising $1.5M to help deploy our first 180 Viit Gen-4 units as part of our Cardiometabolic Risk Observation Programs (CROP) — a population-level monitoring model ...","published_at":"2026-05-20T15:00:00Z","canonical_url":"https://wefunder.com/feed/323853"},{"id":226447,"entity_id":"wefunder:feed_item:226447","title":"How Viit Health Could Change Everyday Care","preview":"Final Days to Join Our Seed Stage Community RoundWe started Viit Health with a simple belief: preventive care should be effortless, accessible, and grounded in real physiological data. Over the past couple of years, our team and clinical partners have worked with thousands of patients to demonstrate what becomes possible when advanced optical sensing technology is paired with rigorous clinical validation.On November 19, we conducted a full live demonstration of our technology for our investor...","published_at":"2025-12-02T19:02:23Z","canonical_url":"https://wefunder.com/feed/226447"},{"id":183225,"entity_id":"wefunder:feed_item:183225","title":"Almost Funded in 6 Days!","preview":"Hello everyone,I want to thank all of you for your overwhelming support during our launch! I'm very happy to tell you that even though it's early, this seems to be our most successful community round yet.Since our public launch last Thursday we are now just $26K away from reaching our fundraising goal!! After seeing this fantastic traction we will aim to extend the round past the initial target, but in the meantime, let's keep on moving forward to reach the fundraising target in record time.L...","published_at":"2025-06-24T23:55:51Z","canonical_url":"https://wefunder.com/feed/183225"},{"id":183124,"entity_id":"wefunder:feed_item:183124","title":"We Are Back!","preview":"Hello everyone,I'm happy to announce that we are back on WeFunder for one last community round before our launch! It's been quite the adventure since we started this journey with all of you back in 2021 during our first community round. Now –four years later– we are one step away from commercialization and extremely excited for this new chapter ahead of us.I wanted to share with you some of the most relevant updates since our last community round in 2023-24:Intellectual Property: In March of ...","published_at":"2025-06-20T21:00:46Z","canonical_url":"https://wefunder.com/feed/183124"},{"id":174903,"entity_id":"wefunder:feed_item:174903","title":"🚨 Viit Health’s Crowdfunding Campaign Ends Tonight – Don’t Miss Out! 🚀","preview":"Dear Viit Health Community,We are deeply grateful for your unwavering support throughout our campaign. As we approach the final hours (ending at 11:59 PM ET tonight), we invite you to join us in making a powerful close.This is your last opportunity to support the future of consumer healthcare and help us create a healthier tomorrow.Thank you to everyone who has been a part of this journey. Let’s make these final moments count!With heartfelt thanks,\u0026nbsp;The Viit Health Team","published_at":"2024-07-30T15:42:53Z","canonical_url":"https://wefunder.com/feed/174903"},{"id":174876,"entity_id":"wefunder:feed_item:174876","title":"🎬 The Final Act: Your Last Chance to Be Part of Viit's Healthcare and Wellness Revolution! 🚀","preview":"Dear Viit Community,As the curtain falls on our Wefunder campaign tomorrow at 11:59 PM ET, we're overwhelmed with gratitude and excitement. This journey has been nothing short of extraordinary, and it's all thanks to you.🏆 Campaign Highlights:850+ visionary investors have joined our mission.$580k+ raised on Wefunder.Additional $2M raised and secured from Venture Capital firms like the Softeq Venture Fund and Sabacica Capital.Assisted by the prestigious Hospital General de México, Bioviit 2.0 ...","published_at":"2024-07-29T18:50:46Z","canonical_url":"https://wefunder.com/feed/174876"},{"id":174858,"entity_id":"wefunder:feed_item:174858","title":"Olympic Finish 🥇🏆","preview":"Hello Viit Community,As we approach the final days of our campaign, the world is rallying behind athletes at the most important global sporting competition: the Olympics.Under this context, we thought that it would be fitting to share some information on how regular blood glucose monitoring can significantly enhance athletic performance:1. Optimized Energy ManagementUnderstanding Energy Levels: Glucose is the body's primary energy source, especially during high-intensity exercise. Regular mon...","published_at":"2024-07-28T22:04:54Z","canonical_url":"https://wefunder.com/feed/174858"},{"id":174849,"entity_id":"wefunder:feed_item:174849","title":"🚀 Viit's Next Big Leap: Bioviit 3.0 🚀","preview":"Exciting news Viit community! We're on the brink of a game-changing development! Coming soon:✅ Our 3rd generation device, Bioviit 3.0, which will integrate Quantum Light Rotation to improve glucose measurement specificity by 20x.✅ Complete the largest multi-centric clinical protocol for glucose measurement in the history of Mexico.✅ Achieve commercial clearance as a pulse oximeter and wellness device.Your investment in these final 3 days isn't just funding – it's fueling a revolution in disea...","published_at":"2024-07-27T22:33:54Z","canonical_url":"https://wefunder.com/feed/174849"},{"id":174833,"entity_id":"wefunder:feed_item:174833","title":"🚨 Last Chance Alert! 🚨","preview":"Viit Health’s crowdfunding campaign on Wefunder ends in 4 days!✅ Bioviit 2.0 is currently in multi-centric protocols –expected to be the largest in the History of Mexico.✅ +800 of investors already on board.✅ +$570k raised so far on WeFunder and + $1.8m from Notorious Angels and VCs.✅ 4 validated biomarker measurements; blood glucose, blood pressure, oxygen saturation and heart rate variability.Don't miss out on being part of our journey. Invest now and make an impact for the future of health...","published_at":"2024-07-26T18:27:37Z","canonical_url":"https://wefunder.com/feed/174833"},{"id":174783,"entity_id":"wefunder:feed_item:174783","title":"Final Countdown: Last Chance to Join Our Wefunder Campaign!","preview":"Hello Viit Community,As we approach the final days of our crowdfunding campaign, we want to take a moment to look back on what we have accomplished with your support!Milestones: Since we began our second crowdfunding campaign, we have been able to achieve the following objectives:Integrated Blood Pressure measurements to our capabilities.Validate each biomarker measurement technique.Activate our final and largest multi-centric calibration protocol where we will measure more than 150K patients...","published_at":"2024-07-25T18:15:44Z","canonical_url":"https://wefunder.com/feed/174783"}],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-06T03:14:17Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-05T23:53:30Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-05T23:53:30Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-03-30T18:51:39Z","as_of":"2026-06-06T03:14:17Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-03-30T18:51:39Z","as_of":"2026-06-06T03:14:17Z","confidence":"medium"}}}}}}